![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|15|3|229-233
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.15, Iss.3, 2015-01, pp. : 229-233
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pregabalin for the treatment of fibromyalgia
By Smith Maree T Moore Brendan J
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of fibromyalgia and its symptoms
By Staud Roland
Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pirlindole in the Treatment of Depression and Fibromyalgia Syndrome
By Branco Jaime C. > Cruz Manuel R.
Clinical Drug Investigation, Vol. 31, Iss. 10, 2011-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fibromyalgia: Mechanisms, Current Treatment and Animal Models
Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacological Treatment of Fibromyalgia Syndrome: New Developments
By Staud Roland
Drugs, Vol. 70, Iss. 1, 2010-01 ,pp. :